Click Here for Customer Exclusives
Proline Sports Nutrition & Equipment,
I was shopping for the product below using Google as which time I saw your Google add. This was the first I heard of your company. I went to your site and liked what I saw and proceeded to order the Optygen HP. The order was placed on late Friday afternoon and was delivered (to my surprise) on Saturday. Your service is awesome as well as your price match guarantee. There is no doubt that I will continue to use you in the future, as well as recommend you to others.
Acetyl-L-carnitine is similar in form to the amino acidL-carnitine and also has some similar functions, such as being involved in the metabolism of food into energy.
The acetyl group that is part of acetyl-L-carnitine contributes to the production of the neurotransmitter acetylcholine, which is required for mental function. Several double-blind clinical trials suggest that acetyl-L-carnitine delays the progression of Alzheimers disease and enhances overall performance in some people with Alzheimers disease. Alzheimers research has been done with the acetyl-L-carnitine form, rather than the L-carnitine form, of this nutrient.
One double-blind trial4 has found that acetyl-L-carnitine may be helpful for people with degenerative cerebellar ataxia, a loss of muscular coordination caused by disease in the cerebellum (the hind part of the brain that controls muscle tone and balance).
Where is it found? Acetyl-L-carnitine is a molecule that occurs naturally in the brain, liver, and kidney. It is also available as a dietary supplement.
1. Pettegrew JW, Klunk WE, Panchalingam K, et al. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer�s disease. Neurobiol Aging 1995;16:1�4.
2. Sano M, Bell K, Cote L, et al. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer�s disease. Arch Neurol 1992;49:1137�41.
3. Cucinotta D, Passeri M, Ventura S, et al. Multicenter clinical placebo-controlled study with acetyl-L-carnitine (LAC) in the treatment of mildly demented elderly patients. Drug Development Res 1988;14:213�6.
4. Sorbi S, Forleo P, Fani C, Piacentini S. Double-blind, crossover, placebo-controlled clinical trial with L-acetylcarnitine in patients with degenerative cerebellar ataxia. Clin Neuropharmacol 2000;23:114�8.
5. No authors listed. Acetyl-L-Carnitine. Altern Med Rev 1999;4:438�41 [review].
6. Thal LJ, Carta A, Clarke WR, et al. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer�s disease. Neurology 1996;47:705�11.
7. Rai G, Wright G, Scott L, et al. Double-blind, placebo controlled study of acetyl-L-carnitine in patients with Alzheimer�s dementia. Curr Med Res Opin 1990;11:638�47.